(Q46908676)

English

Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol

scientific article published in December 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16433188

Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16433188

1

object named as

Jones RN

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16433188

author name string

Fritsche TR

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16433188

Sader HS

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16433188

Goldstein BP

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16433188

publication date

1 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16433188

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Journal of Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16433188

17

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16433188

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16433188

593-600

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16433188

Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

Origin, structure, and activity in vitro and in vivo of dalbavancin

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

In vitro evaluation of BI 397, a novel glycopeptide antimicrobial agent

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptide

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

Antistaphylococcal activity of dalbavancin, an experimental glycopeptide

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

Population pharmacokinetic analysis of dalbavancin, a novel lipoglycopeptide

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

Human pharmacokinetics and rationale for once-weekly dosing of dalbavancin, a semi-synthetic glycopeptide

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

Pharmacokinetics and excretion of dalbavancin in the rat.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

Activities of dalbavancin in vitro and in a rabbit model of experimental endocarditis due to Staphylococcus aureus with or without reduced susceptibility to vancomycin and teicoplanin

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

Safety and efficacy of glycopeptide antibiotics

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

Novel agents for the treatment of resistant Gram-positive infections

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

Antimicrobial resistance to linezolid

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

Validation of commercial dry-form broth microdilution panels and test reproducibility for susceptibility testing of dalbavancin, a new very long-acting glycopeptide

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.593

21 January 2018

Identifiers

10.1179/JOC.2005.17.6.593

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16433188

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16433188

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46908676&oldid=2137487117"